AI Visibility Scorecard
discoverfabry.com · Healthcare
Borderline visible. AI bots can crawl Sanofi, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 1 times
Claude
#797,207 of 924,420 in Healthcare for AI visibility
<1
4
AEO Visibility
iNear-invisible · 3.5/10
20
Muse Index Score
iAI agent readiness
Basic · 20/100
0
AI Adoption
iNone detected · 0/100
from our crawl and measurement
"Learn about Fabry disease and its causes, symptoms, diagnosis, testing, and how it affects women. Discover why early detection is vital for effective management." That is how About Fabry Disease introduces itself. When AI engines look at it, they find little to work with. It scores 3.5 out of 10.
Our crawl found structured data on the page (Article) and a readable heading structure. It is missing an llms.txt file and a sitemap.
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Fair
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 3.5/10, Sanofi is crawlable but under-signaled - fixable, and the signals above are where to start.
What causes Fabry disease?
Fabry disease is a genetic disorder caused by alterations to the GLA gene.4 This gene is important because it produces an enzyme called alpha-galactosidase A, or alpha-GAL, which helps remove a fatty substance called globotriaosylceramide (GL-3) from blood vessels and organs.6,8 In Fabry disease, changes to the GLA gene can sometimes cause the body to make less alpha-GAL, and that can lead to a buildup of GL-3.
Who does Fabry disease affect?
Fabry disease can impact individuals of any gender, race, background, or age. Classic Fabry disease begins in childhood and it tends to worsen in adults. Previously, it was believed that only males could develop the disease and females could be only carriers who remained asymptomatic.
What are the symptoms of Fabry disease?
Fabry disease symptoms can be very different from person to person. Some people may have only one symptom, while others may have many. Symptoms may be mild or more severe, and can also change as time goes on.
How is Fabry disease diagnosed?
Fabry disease is typically diagnosed with a simple test, using a blood or saliva sample. Alpha-GAL enzyme levels can be tested with a blood sample. Alterations in the GLA gene can be tested with either blood or saliva samples. Males can be diagnosed with enzyme.
Is this your brand?
The exact fixes for Sanofi
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Sanofi.
Scored by Engagemii on August 11, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/discoverfabry
Cite this score: Engagemii (2026). "AEO Score for Sanofi." Retrieved from https://engagemii.com/aeo/brands/discoverfabry
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform